Hypercoagulation
(Die Seite wurde neu angelegt: „'''single mechanisms were singled out''' {{tp|p=32350161|t=2020. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China |pdf=|usr=}} …“) |
|||
| (Eine dazwischenliegende Version von einem Benutzer wird nicht angezeigt) | |||
| Zeile 1: | Zeile 1: | ||
'''single mechanisms were singled out''' | '''single mechanisms were singled out''' | ||
| − | + | {{tp|p=32490726|t=2020. Thromboinflammatory response in SARS-CoV-2 sepsis.|pdf=|usr=007}} | |
| + | {{ttp|p=32436629|t=2020. High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis.|pdf=|usr=007}} | ||
| + | {{tp|p=32512491|t=2020. COVID-19-related complications and decompression illness share main features.: Could the SARS-CoV2-related complications rely on blood foaming?|pdf=|usr=007}} | ||
| + | {{tp|p=32486469|t=2020. COVID-19 Related Coagulopathy: A Distinct Entity?|pdf=|usr=007}} | ||
{{tp|p=32350161|t=2020. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China |pdf=|usr=}} | {{tp|p=32350161|t=2020. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China |pdf=|usr=}} | ||
{{tp|p=32357997|t=2020. Coagulopathy associated with COVID-19 |pdf=|usr=}} | {{tp|p=32357997|t=2020. Coagulopathy associated with COVID-19 |pdf=|usr=}} | ||
{{tp|p=32073213|t=2020. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia |pdf=|usr=}} | {{tp|p=32073213|t=2020. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia |pdf=|usr=}} | ||
| + | {{ttp|p=32441844|t=2020. Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2.|pdf=|usr=007}} | ||
| + | {{tp|p=32437597|t=2020. Covid-19, Angiogenesis, and ARDS Endotypes.|pdf=|usr=007}} | ||
| + | {{tp|p=32437596|t=2020. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.|pdf=|usr=007}} | ||
{{tp|p=32246317|t=ä. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 |pdf=|usr=}} | {{tp|p=32246317|t=ä. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 |pdf=|usr=}} | ||
{{tp|p=32335420|t=ä. Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients |pdf=|usr=}} | {{tp|p=32335420|t=ä. Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients |pdf=|usr=}} | ||
| Zeile 24: | Zeile 30: | ||
{{tp|p=32133825|t=2020. Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19 |pdf=|usr=}} | {{tp|p=32133825|t=2020. Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19 |pdf=|usr=}} | ||
{{tp|p=32418867|t=ä. COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept |pdf=|usr=}} | {{tp|p=32418867|t=ä. COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept |pdf=|usr=}} | ||
| + | {{tp|p=32479682|t=2020. Preeclampsia-like syndrome induced by severe COVID-19: a prospective observational study.|pdf=|usr=007}} | ||
| + | {{ttp|p=32506640|t=2020. Viral Infections and Their Relationship with Catastrophic Antiphospholipid Syndrome: A Possible Pathogenic Mechanism of Severe COVID-19 Thrombotic Complications.|pdf=|usr=007}} | ||
| + | {{tp|p=32384917|t=2020. COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review.|pdf=|usr=008}} | ||
Aktuelle Version vom 27. Juni 2020, 13:14 Uhr
single mechanisms were singled out
32490726 2020. Thromboinflammatory response in SARS-CoV-2 sepsis.
| 32436629 2020. High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis. |
32512491 2020. COVID-19-related complications and decompression illness share main features.: Could the SARS-CoV2-related complications rely on blood foaming?
32486469 2020. COVID-19 Related Coagulopathy: A Distinct Entity?
32350161 2020. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China
32357997 2020. Coagulopathy associated with COVID-19
32073213 2020. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
| 32441844 2020. Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2. |
32437597 2020. Covid-19, Angiogenesis, and ARDS Endotypes.
32437596 2020. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
32246317 ä. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
32335420 ä. Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients
32267008 2020. Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability
| 32330308 2020. COVID19 coagulopathy in Caucasian patients |
| 32304581 2020. Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis |
32172226 2020. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
32302438 2020. Hypercoagulability of COVID-19 patients in Intensive Care Unit A Report of Thromboelastography Findings and other Parameters of Hemostasis
32344457 2020. Uncertainties on the prognostic value of D-dimers in COVID-19 patients
32306492 2020. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19
32302459 2020. COVID-19 and acute coagulopathy in pregnancy
32324960 2020. Laboratory haemostasis monitoring in COVID-19
32302453 2020. Thromboinflammation and the hypercoagulability of COVID-19
| 32302448 2020. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome |
32367765 2020. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count
32279286 2020. Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring
32316063 2020. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure
32374920 2020. Viscoelastic testing in COVID-19: a possible screening tool for severe disease?
32220276 2020. Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia
32133825 2020. Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19
32418867 ä. COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept
32479682 2020. Preeclampsia-like syndrome induced by severe COVID-19: a prospective observational study.
| 32506640 2020. Viral Infections and Their Relationship with Catastrophic Antiphospholipid Syndrome: A Possible Pathogenic Mechanism of Severe COVID-19 Thrombotic Complications. |
32384917 2020. COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review.
